Mineralys Therapeutics, Inc. MLYS Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s net income?
- Mineralys Therapeutics, Inc. (MLYS) reported net income of -$39.34M in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s net income changed year-over-year?
- Mineralys Therapeutics, Inc.'s net income increased by 6.8% year-over-year, from -$42.21M to -$39.34M.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s net income?
- Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s net income has grown at a 73.1% compound annual growth rate (CAGR), from -$29.8M to -$154.65M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.